Position in BCYC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,543,952
+$532,424 QoQ
Shares Held
979,300
+72.8% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,450,872,574 across 330 Biotechnology names. BCYC ranks #88 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in BCYC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,543,952 | 979,300 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,011,528 | 566,600 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,014,738 | 518,700 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,212,880 | 318,400 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,559,735 | 301,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,773,000 | 269,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,168,938 | 272,600 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,614,432 | 326,800 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,125,930 | 165,700 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,907,440 | 105,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,647,380 | 82,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,809,368 | 70,900 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,316,613 | 61,900 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $2,570,696 | 153,200 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,825,828 | 64,399 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,454,405 | 73,179 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $443,256 | 14,600 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $800,516 | 26,800 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,457,540 | 81,200 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,133,475 | 59,500 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,175,778 | 74,700 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $256,620 | 18,800 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||